Actual Associations between HLA Haplotype and Graves’ Disease Development

Abstract

The association between HLA and the risk of Graves’ disease (GD) has been analyzed for many years. However, the results were often inconsistent and mostly regarded Asian populations. The purpose of our study was to perform HLA genotyping using a next-generation sequencing (NGS) method in Caucasians, to find out which alleles are eventually correlated with GD morbid-ity as well as which of them can be considered protective. HLA-A,-B,-C,-DQB1,-DRB1 were genotyped using a next-generation sequencing method in 2376 persons, including 159 GD patients and 2217 healthy controls. We have demonstrated a significant association between the risk of GD and the following alleles: HLA-B*08:01,-B*39:06,-B*37:01,-C*07:01,-C*14:02,-C*03:02,-C*17:01,-DRB1*03:01,-DRB1*11:01,-DRB1*13:03,-DRB1*01:03,-DRB1*14:01,-DQB1*03:01, DQB1*02:01. The alleles HLA-B*39:06,-B*37:01,-C*14:02,-C*03:02,-C*17:01,-DRB1*14:01 are novel GD-associated, previously not-reported independent ones with no linkage disequilibrium with other high-risk alleles. On the other hand, the frequencies of HLA-B*07:02,-C*07:02,-C*03:04, DRB1*07:01,-DQB1*02:02,-DQB1*03:03 were significantly lower in GD compared to controls. This study demonstrated the actual relationships between HLA and GD based on the NGS method and provided a novel set of alleles as a reliable tool for an individual personalized risk assessment.